01
Phase I–III Vaccine Trials
Clinical trial capabilities spanning early-phase development through Phase III studies.
Services
Services
OUR VACCINE CLINICAL TRIAL CAPABILITIES
01
Clinical trial capabilities spanning early-phase development through Phase III studies.
02
Controlled dosing with intensive medical oversight and post-vaccination monitoring.
03
Established volunteer database for efficient recruitment and participant retention (14 000+)
04
Monitoring of local and systemic reactions, adverse events, and safety signals.
05
Sample collection for antibody, neutralizing antibody, and other immune response endpoints.
06
Experience with mRNA, recombinant, conjugate, protein-based, and other vaccine technologies.
07
Clinical facilities for intensive observation, scheduled visits, and long-term follow-up.
08
Regulatory support and clinical trial conduct within the EU and ICH-GCP framework.
09
CRO and clinical site teams working together throughout study delivery.
22+ Vaccine Clinical Trials
1,760+ Participants Enrolled
Phase I–III
19+ Years in Vaccine Research
OUR FIH CAPABILITIES
01
PI – Clinical Pharmacology expert with 25+ years in clinical research.
11 sub-investigators in Cardiology, Neurology, Endocrinology, Intensive Care.
02
Dedicated critical care team & fully equipped monitoring unit
5 dedicated beds for continuous 24-hour vital signs monitoring.
03
7 Clinical research coordinators with 6+ years of experience.
14 clinical study nurses.
04
Multiple proven channels. One recruitment strategy.
Volunteer Database · Recruitment Partners · Referrals · Digital Outreach · Patient Networks
05
15
beds dedicated for Phase I participants
Advanced Research Equipment
2 Hospital Partnerships
Emergency care access with dedicated medical transport
06
Up to 18
Study participants screened per day
07
In-house accommodation for study participants for up to 15 consecutive days
08
24 hours a day, 7 days a week clinical trial conduct at the site.
09
~35 days
regulatory approval
~10 days
to activate site & full team
Recruitment Ready
OUR FIH CAPABILITIES
01
PI – Clinical Pharmacology expert with 20+ years in clinical research.
9 sub-investigators in Cardiology, Neurology, Endocrinology, Allergology.
02
Dedicated critical care team with all equipment and drugs.
3 beds for 24-hour vital signs monitoring.
03
6 Clinical Research Coordinators with 5+ years of experience.
12 research-experienced nurses.
04
Multiple proven channels to recruit healthy volunteers and patients.
Database
HV Partner
Referrals
Online
Patients
05
15
beds dedicated for Phase I participants
Up to 15
days in-house stay
3
beds for continuous monitoring
06
Up to 16 screenings per day. Includes sentinel patients enrollment.
07
In-house stay of volunteers up to 15 days in the clinical research center.
08
24 hours a day, 7 days a week clinical trial conduct at the center.
09
~35 days
regulatory approval
~10 days
to activate site & full team
Efficient.
Predictable.
Ready.
